NEUREN PHARMACEUTICALS LIMITED
NEU - Further Validation of NNZ-2566 as a Traumatic Brain Injury Treatment - Mr David Clarke, CEO
Wed, 14 Feb 2007 01:30PM
Loading presentation... If nothing happens, you may need to install
Flash and/or enable javascript in your browser.
Send a link for this presentation to a friend
Loading audio... If nothing happens please either:
Click to listen to audio on your default player or
Download the latest version of the Flash Player
Click to listen to audio on your default player or
Download the latest version of the Flash Player
Wed, 14 Feb 2007
01:30PM Australia/NSW